GBT - Global Blood Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development87,80761,26336,65716,324
Selling General and Administrative31,43820,3649,7364,187
Non Recurring----
Total Operating Expenses119,24581,62746,39320,511
Operating Income or Loss-119,245-81,627-46,393-20,511
Income from Continuing Operations
Total Other Income/Expenses Net2,221-84133-296
Earnings Before Interest and Taxes-119,245-81,627-46,393-20,511
Interest Expense----
Income Before Tax-117,024-82,468-46,360-20,807
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-117,024-82,468-46,360-20,807
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-117,024-82,468-46,360-20,807
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-117,024-82,468-50,540-23,772